The Institutional Biosafety Committee (IBC) at NYMC reviews all research involving recombinant or synthetic nucleic molecules. The IBC reviews and approves all projects and is responsible for ensuring compliance in accordance with the NIH Guidelines. Click to learn more: IBC Registration Guide & FAQs.
IBC meetings take place every month on the third Thursday the month. We ask that protocols be submitted by the Friday before the meeting to allow for sufficient review. Here are the dates for IBC 2023:
| January 19 | February 16 | March 16 | April 20 | |||
|---|---|---|---|---|---|---|
| May 18 | June 15 | July 20 | August 17 | |||
| September 21 | October 19 | November 16 | December 21 |
The American Biological Safety Association (ABSA) International Risk Group Database consists of international risk group classifications for bacteria, viruses, fungi, and parasites. In many countries, including the United States, infectious agents are categorized into risk groups based on their relative risk. Depending on the country and/or organization, this classification system might take the following factors into consideration: pathogenicity of the organism; mode of transmission and host range; availability of effective preventive measures (e.g., vaccines); availability of effective treatment (e.g., antibiotics); and other factors. The risk group database can be used to help investigators determine the risk group of an organism and the proper biosafety level for working with the agent.